Bioline Rx Ltd - ADR has a share price target of US$ 33, revenue growth forecast of -79.9%, and profit growth estimate of -42.2% for FY25, based on top 2 analyst calls.
Upgrade Your Plan
You need to upgrade your subscription plan to access this feature